Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-021516
Filing Date
2025-05-01
Accepted
2025-05-01 16:04:48
Documents
86
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ardx-20250331.htm   iXBRL 10-Q 1415719
2 EX-10.1 ardx-20250331xex101.htm EX-10.1 80527
3 EX-10.2 ardx-20250331xex102.htm EX-10.2 75248
4 EX-10.3 ardx-2025x0331xex103.htm EX-10.3 40943
5 EX-31.1 ardx-20250331xex311.htm EX-31.1 9745
6 EX-31.2 ardx-20250331xex312.htm EX-31.2 9783
7 EX-32.1 ardx-20250331xex321.htm EX-32.1 6438
13 ardx-20250331_g1.jpg GRAPHIC 75659
14 image_0.jpg GRAPHIC 110
  Complete submission text file 0001628280-25-021516.txt   7583726

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ardx-20250331.xsd EX-101.SCH 51501
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ardx-20250331_cal.xml EX-101.CAL 72592
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ardx-20250331_def.xml EX-101.DEF 232092
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ardx-20250331_lab.xml EX-101.LAB 613853
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ardx-20250331_pre.xml EX-101.PRE 444037
89 EXTRACTED XBRL INSTANCE DOCUMENT ardx-20250331_htm.xml XML 1010419
Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36485 | Film No.: 25902940
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)